Website Headline

Enter Your website sub headline here

Risk factors for rhinophyma

Rhinophyma involves an increase in sebaceous, or oil, glands and underlying connective tissues in the face. According to , the exact cause is still unclear, and several factors may play a role. These include a combination of conditions that affect the immune system, nerves, and blood vessels. The precursor to rhinophyma is acne rosacea, a long-term skin condition that is more common in females. A subset of people with acne rosacea later develops rhinophyma. Rhinophyma occurs more often in males, at a ratio ranging from and it typically develops in people aged 50–70. Due to the higher prevalence in males, scientists suspect that male hormones increase the risk. The exact cause of rhinophyma is not well understood, but it is believed to be a complication of rosacea, a chronic skin condition that affects the face. Rosacea causes inflammation and redness on the face, especially on the cheeks, nose, chin, and forehead. In some people, the condition can progress to rhinophyma, which is characterized by the thickening of the skin on the nose and an increase in the number and size of sebaceous glands. There are some risk factors that have been associated with the development of rhinophyma, including:. IS RHINOPHYMA


Other Topics in Patient Care & Health Info

As a cosmetic surgery centre, cutis is equipped in providing the highest level of care and safety to our patients. During a consultation with cutis' facial plastic surgeon, dr. Ron lemckert, ent, a general health assessment will be made to ensure treatment suitability. The treatment can be performed under local or general anesthetic and can last between one to three hours depending on the size of the rhinophyma. Our highly trained professionals take every safeguard to ensure our patients are fully informed and prepared for both pre and post-treatment care. How is rhinophyma diagnosed? Rhinophyma is diagnosed clinically with erythema, telangiectasias, and skin thickening in the nasal region. The lower two-thirds of the nose is affected more than the upper third. There is no specific test for rhinophyma. Diagnostic confirmation is by histology. Rosacea was divided into four stages by wilkin in 1994: pre-rosacea, vascular rosacea, inflammatory rosacea, and late rosacea. Rhinophyma belongs to the "late rosacea" stage. Further refinement of rosacea in 2002 by the national rosacea society (nrs) allowed standardization of rosacea. The diagnosis of rosacea requires the presence of one or more primary features and one or more secondary features. The